Perrault syndrome: genes and variants
Explore variant evidence for Perrault syndrome across 4 analyzed proteins (HSD17B4, DAP3, FBN1, CLDN14). Linked ClinVar records include 32 pathogenic or likely pathogenic variants, 159 variants of uncertain significance and 35 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Perrault syndrome
HSD17B4: Peroxisomal multifunctional enzyme type 2
A peroxisomal multifunctional enzyme that carries out two steps in fatty-acid beta-oxidation. It processes straight-chain and branched fatty acids as well as bile-acid intermediates, and loss of the protein causes D-bifunctional protein deficiency.
28 ClinVar pathogenic / likely pathogenic and 194 uncertain variants in HSD17B4 have source records linked to Perrault syndrome. Association strength is not clinical gene validity.
DAP3: Small ribosomal subunit protein mS29
It forms part of the small mitochondrial ribosomal subunit, supporting synthesis of proteins encoded by mitochondrial DNA, and also participates in cell-death signaling. Biallelic pathogenic variants can cause Perrault syndrome 7, with sensorineural hearing loss and ovarian dysfunction in affected females, sometimes accompanied by neurological features.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in DAP3 have source records linked to Perrault syndrome. Association strength is not clinical gene validity.
FBN1: Fibrillin-1
Its fibrillin-1 microfibrils provide mechanical support to elastic tissues and regulate local availability of growth factors such as TGF-beta. Pathogenic variants cause Marfan syndrome and related fibrillinopathies affecting the aorta, skeleton, eyes, skin, and lungs.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in FBN1 have source records linked to Perrault syndrome. Association strength is not clinical gene validity.
CLDN14: Claudin-14
A claudin in tight junctions that helps control movement between epithelial cells. Loss-of-function variants can cause recessive, nonsyndromic hearing loss.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CLDN14 have source records linked to Perrault syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Perrault syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| HSD17B4 R248C | 248 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★★) |
| HSD17B4 L405P | 405 | Enoyl-CoA hydratase 2 | Pathogenic / likely pathogenic (★★) |
| HSD17B4 N457Y | 457 | Enoyl-CoA hydratase 2 | Pathogenic / likely pathogenic (★★) |
| HSD17B4 R506C | 506 | MaoC-like | Pathogenic / likely pathogenic (★★) |
| HSD17B4 R506H | 506 | MaoC-like | Pathogenic / likely pathogenic (★★) |
| HSD17B4 N457D | 457 | Enoyl-CoA hydratase 2 | Pathogenic / likely pathogenic (★★) |
| HSD17B4 W273C | 273 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★★) |
| HSD17B4 H406Y | 406 | Enoyl-CoA hydratase 2 | Pathogenic / likely pathogenic (★★) |
| HSD17B4 I516T | 516 | MaoC-like | Pathogenic / likely pathogenic (★★) |
| HSD17B4 A34V | 34 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★★) |
| HSD17B4 N176D | 176 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★★) |
| HSD17B4 V218L | 218 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★★) |
| HSD17B4 S372F | 372 | Enoyl-CoA hydratase 2 | Pathogenic / likely pathogenic (★★) |
| HSD17B4 L736H | 736 | SCP2 | Pathogenic / likely pathogenic (★★) |
| HSD17B4 N98D | 98 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 N98K | 98 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 N98I | 98 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 R248L | 248 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 R251L | 251 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 M1I | 1 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 A100S | 100 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 Y156H | 156 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 A196E | 196 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 H515Q | 515 | MaoC-like | Pathogenic / likely pathogenic (★) |
| FBN1 C623S | 623 | EGF-like 10 | Pathogenic / likely pathogenic (★) |
| HSD17B4 M1L | 1 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 H123D | 123 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 L178F | 178 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 C535F | 535 | MaoC-like | Pathogenic / likely pathogenic (★) |
| DAP3 E392K | 392 | Pathogenic / likely pathogenic (★) | |
| CLDN14 V85D | 85 | Transmembrane | Pathogenic / likely pathogenic |
| DAP3 C395Y | 395 | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Perrault syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| HSD17B4 A196V | 196 | (3R)-hydroxyacyl-CoA dehydrogenase | Conflicting reports (★) | +6: A196E at the same position is pathogenic; REVEL 0.945 |
| HSD17B4 N98S | 98 | (3R)-hydroxyacyl-CoA dehydrogenase | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; N98K at the same position is pathogenic; REVEL 0.842 |
| HSD17B4 L405F | 405 | Enoyl-CoA hydratase 2 | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; L405P at the same position is pathogenic; REVEL 0.782 |
Which prediction tools work for Perrault syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- ESM1b (LLR): 98 out of 100
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 97 out of 100
- REVEL: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 89 out of 100
- SIFT: 85 out of 100
- phyloP: 72 out of 100
- SpliceAI: 57 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 47 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Bifunctional peroxisomal enzyme deficiency also has ClinVar records linked to HSD17B4 variants; they fall partly in the same places as the Perrault syndrome variants (33 pathogenic / likely pathogenic).
- Marfan syndrome also has ClinVar records linked to FBN1 variants; they fall mostly in different places as the Perrault syndrome variants (434 pathogenic / likely pathogenic).
- Familial thoracic aortic aneurysm and aortic dissection also has ClinVar records linked to FBN1 variants; they fall mostly in different places as the Perrault syndrome variants (406 pathogenic / likely pathogenic).
- Isolated thoracic aortic aneurysm also has ClinVar records linked to FBN1 variants; they fall mostly in different places as the Perrault syndrome variants (12 pathogenic / likely pathogenic).
- Marfan syndrome/loeys-dietz syndrome/familial thoracic aortic aneurysms and dissections also has ClinVar records linked to FBN1 variants; they fall mostly in different places as the Perrault syndrome variants (10 pathogenic / likely pathogenic).
- Acromicric dysplasia also has ClinVar records linked to FBN1 variants; they fall mostly in different places as the Perrault syndrome variants (6 pathogenic / likely pathogenic).
Diseases related to Perrault syndrome
- Familial thoracic aortic aneurysm and aortic dissection, also linked to FBN1
- Marfan syndrome, also linked to FBN1
- Autosomal recessive nonsyndromic hearing loss, also linked to CLDN14
- Bifunctional peroxisomal enzyme deficiency, also linked to HSD17B4
- Hearing loss, also linked to CLDN14
- Connective tissue disease, also linked to FBN1
- Familial aortopathy, also linked to FBN1
- Isolated thoracic aortic aneurysm, also linked to FBN1
- Marfan syndrome/loeys-dietz syndrome/familial thoracic aortic aneurysms and dissections, also linked to FBN1
- Deafness, also linked to CLDN14
- Acromicric dysplasia, also linked to FBN1
- Ectopia lentis 1, isolated, autosomal dominant, also linked to FBN1
Frequently asked questions
Which genes have records linked to Perrault syndrome?
This view contains 4 analyzed proteins: HSD17B4, DAP3, FBN1, CLDN14. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 32 pathogenic or likely pathogenic variants, 159 variants of uncertain significance and 35 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 3 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 264 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center